Elevance Health (ELV)

The sleeper story here is AI operational leverage scaling faster than expected - 22 million members actively using tools, 70% reduction in prior auth denials, and measurable productivity gains across 60,000+ associates. This isn't pilot programs anymore; it's embedded infrastructure driving real margin expansion. The obvious headline is the raised guidance, but strip out the $1 nonrecurring gain and you get a modest 25-cent operational beat. The binding constraint remains regulatory pressure, highlighted by the $935 million CMS risk adjustment accrual that signals Medicare Advantage faces continued scrutiny. Most revealing quote: 'We're not approaching AI as a separate technology element or experimentation' - they're treating this as core infrastructure, not innovation theater. My view changes if ACA retention rates deteriorate significantly through Q2 effectuation or if the CMS compliance process reveals broader risk adjustment issues across the industry.